Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors-Reference-Cited by-同舟云学术

Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors

Published:2022-09 Issue:5 Volume:42 Page:1474-1493
ISSN:0271-5333
Container-title:RadioGraphics
language:en
Short-container-title:RadioGraphics

Author:

Kurokawa Ryo¹^ORCID,Kurokawa Mariko¹^ORCID,Baba Akira¹^ORCID,Ota Yoshiaki¹^ORCID,Pinarbasi Emile¹,Camelo-Piragua Sandra¹^ORCID,Capizzano Aristides A.¹^ORCID,Liao Eric¹,Srinivasan Ashok¹^ORCID,Moritani Toshio¹^ORCID

Affiliation:

1. From the Division of Neuroradiology, Department of Radiology (R.K., M.K., A.B., Y.O., A.A.C., E.L., A.S., T.M.) and Department of Pathology (E.P., S.C.P.), Michigan Medicine, University of Michigan, 1500 E Medical Center Dr, UH B2, Ann Arbor, MI 48109; and Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan (R.K., M.K.).

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/rg.210236

Reference66 articles.

1. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

2. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

3. cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)

4. cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant

5. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Explainability based Panoptic brain tumor segmentation using a hybrid PA-NET with GCNN-ResNet50;Biomedical Signal Processing and Control;2024-08

2. Diagnostic accuracy of a machine learning-based radiomics approach of MR in predicting IDH mutations in glioma patients: a systematic review and meta-analysis;Frontiers in Oncology;2024-07-30

3. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges;International Journal of Molecular Sciences;2024-07-21

4. Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance;American Journal of Neuroradiology;2024-06-27

5. Neuroimaging Features of Cytokine-related Diseases;RadioGraphics;2024-06-01